Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-07 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |